AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
Tallennettuna:
MAHAN, S., ET AL., AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?. Research in Developmental Disabilities, Vol. 31, no. 6 (2010), p. 1561-1569.
Ref.
171346
Sijainti:
SIIS R.775 Archivo
Palabras clave:
Discapacidad intelectual, Efectos no deseados, Fármacos, Psicótropos, Tratamiento médico
Discapacidad intelectual, Efectos no deseados, Fármacos, Psicótropos, Tratamiento médico
Samankaltaisia teoksia: AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
- SIDE EFFECT PROFILES OF ATYPICAL ANTIPSYCHOTICS, TYPICAL ANTIPSYCHOTICS, OR NO PSYCHOTROPIC MEDICATIONS IN PERSONS WITH MENTAL RETARDATION
- PSYCHOTROPIC MEDICATION FOR ADHD
- RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
- GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- USE OF A REVISED VERSION OF THE PSYCHOTROPIC MEDICATION EFFICACY GRAPH
- MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME